AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 177 filers reported holding AXSOME THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $655,358 | -79.1% | 9,377 | -78.5% | 0.00% | -100.0% |
| Q2 2023 | $3,128,856 | +421.9% | 43,541 | +348.0% | 0.00% | – |
| Q1 2023 | $599,530 | -24.7% | 9,720 | -5.9% | 0.00% | -100.0% |
| Q4 2022 | $796,599 | +106.9% | 10,328 | +19.6% | 0.00% | – |
| Q3 2022 | $385,000 | +15.6% | 8,634 | -0.6% | 0.00% | – |
| Q2 2022 | $333,000 | +57.8% | 8,686 | +70.7% | 0.00% | – |
| Q1 2022 | $211,000 | -13.5% | 5,088 | -31.4% | 0.00% | – |
| Q3 2021 | $244,000 | -72.3% | 7,418 | -43.2% | 0.00% | -100.0% |
| Q2 2021 | $882,000 | +9.7% | 13,064 | -8.0% | 0.00% | 0.0% |
| Q1 2021 | $804,000 | -32.9% | 14,195 | -3.5% | 0.00% | 0.0% |
| Q4 2020 | $1,199,000 | +46.2% | 14,717 | +27.8% | 0.00% | 0.0% |
| Q3 2020 | $820,000 | -17.3% | 11,519 | -4.4% | 0.00% | 0.0% |
| Q2 2020 | $991,000 | +213.6% | 12,046 | +124.4% | 0.00% | – |
| Q1 2020 | $316,000 | -59.3% | 5,368 | -28.7% | 0.00% | -100.0% |
| Q4 2019 | $777,000 | – | 7,525 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |